Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
36,566,451
-
Share change
-
+1,782,871
-
Total reported value
-
$393,738,047
-
Put/Call ratio
-
140%
-
Price per share
-
$10.77
-
Number of holders
-
138
-
Value change
-
+$16,141,553
-
Number of buys
-
86
-
Number of sells
-
53
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2019
As of 30 Sep 2019,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,566,451 shares.
The largest 10 holders included
Partner Fund Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., FRED ALGER MANAGEMENT, LLC, Sarissa Capital Management LP, Palo Alto Investors LP, Nuveen Asset Management, LLC, MACQUARIE GROUP LTD, and GOLDMAN SACHS GROUP INC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.